Project Grant R01HL174461
Award Date
6/5/25
Completion Date
3/31/30
Dollars Obligated
$721K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,981,077 to support research investigating the molecular mechanisms underlying the circadian regulation of cardiac ion channel genes and their impact on arrhythmia susceptibility. The 4-year award, effective July 9, 2024, will be performed by the University of Kentucky Research Foundation to address critical knowledge gaps in...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $143,829 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The University of Kentucky Research Foundation. The grant, effective January 1, 2025, supports a 5-year research project to: 1) establish human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as models for studying how the intrinsic cardiomyocyte circadian clock impacts cell size and function, and 2) determine if genetic...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $691,124 to the Regents of the University of Michigan to study the relationship between circadian disruption and cardiometabolic risk during the transition from adolescence to young adulthood. The research aims to explore how persistent circadian disruption, including misaligned sleep, eating, and activity patterns, may lead to...
This federal Project Grant award of $393,750 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports a research project focused on developing a computational approach for predicting and preventing arrhythmias, a leading cause of sudden cardiac death. The project aims to discover effective antiarrhythmic drug therapies and optimal clinical markers for arrhythmia risk prediction by leveraging mathematical modeling,...
The National Heart, Lung, and Blood Institute (NHLBI) awarded The Trustees of Columbia University in the City of New York a $821,982 Project Grant under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837). The grant, awarded on July 15, 2024, will fund a 5-year research project to investigate variability in sleep timing as a potential new risk factor for cardiovascular disease (CVD) among women. The study will leverage two racially and ethnically diverse cohorts of women...
This $653,854 Project Grant was awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The purpose of the grant is to study the impact of cardiomyocyte-selective modulation of natriuretic peptide signaling pathways on cardiomyopathy progression and ventricular arrhythmia susceptibility in preclinical models. The specific aims are to: 1) Define how cardiomyocyte-specific modulation of PKG1 activity modifies cardiomyopathy...
This $633,720 Project Grant awarded by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research to unveil the prevalence and biological roles of protein arginylation in cardiovascular development and disease. The key goals are to: 1) develop a proteomics platform to comprehensively profile arginylation sites in cardiac cells and tissues, 2) elucidate the impacts of arginylation on epigenetic mechanisms and cardiac cell functions, and 3)...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $1,411,136 to The Washington University in St. Louis to study the role of circadian rhythms in organ transplantation. The key objectives are to: Develop a model to predict biological rhythms and circadian clock function in organ donors, leveraging a partnership with the Mid-America Transplant Services organ procurement organization. This will generate the first...
This Project Grant award of $133,410 from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate the relationship between sleep quality, sleep apnea, and cardiac aging. The study aims to leverage longitudinal sleep data from the Korean Genome and Epidemiology Study to assess how impaired sleep patterns accelerate cardiovascular disease risk over a 12-year period. The research will focus on...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), under the Cardiovascular Diseases Research program (CFDA 93.837), totals $618,126 and supports research into the mechanisms by which the cytokine interleukin-6 (IL-6) contributes to ventricular tachyarrhythmias and sudden cardiac death, particularly in the context of obesity-related inflammation. The research aims to elucidate how IL-6 trans-signaling triggers...